Shares of Biogen Inc. BIIB shed 3.41% to $150.03 Friday, on what proved to be an all-around mixed trading session for the ...

In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...

The Nasdaq is due to announce any changes to the Nasdaq 100 index as part of its annual reconstitution at 8 p.m. ET Friday.

This summary covers key developments in health news, including Mitsubishi Pharma's bidding war, legal actions involving J&J ...

Investors in some of the S&P 500’s worst performers may be on the verge of a so-called dead-cat bounce. History shows stocks ...

The buzzword is everywhere this month, from the Massachusetts Competitive Partnership to the Greater Boston Chamber of ...

Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...

Major indices delivered a mixed performance on Friday as the blue-chip Dow Jones turned in its seventh-consecutive losing ...

The McKean County District Attorney has declared a health emergency after receiving reports of drugs being shipped into the ...

Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Blood Brain Barrier Technologies Market 2024" report has been added to ...

According to Research by SNS Insider, the global Autoimmune Disease Therapeutics Market growth is driven by rising demand for biologics, innovative treatments, and advancements in technology and ...

Wall Street trading got off to a mixed start on Friday after the blue-chip Dow Jones turned in its sixth-consecutive losing session a day earlier.